Marpai (MRAI) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
26 Dec, 2025Executive summary
Achieved a significant turnaround in 2024, reducing net and operating losses through cost controls and efficiency initiatives while investing in growth and profitability.
Revenue declined year-over-year and sequentially, but management remains focused on revenue growth, customer experience, and profitability, with new service launches and operational improvements.
Leadership is highly invested and committed to aligning company performance with shareholder interests.
Management expects new product launches and continued cost streamlining to drive growth and profitability in 2025.
Financial highlights
Q4 2024 net revenues were $6.6M, down 6% sequentially; full year 2024 net revenues were $28.2M, down 24.2% year-over-year.
Q4 2024 net loss was $1.2M, a 67.5% year-over-year improvement; full year net loss was $22.1M, a 23.2% improvement.
Q4 2024 operating loss was $2.7M, 12.2% lower sequentially; full year operating loss was $22.1M, 21.1% lower year-over-year.
Adjusted EBITDA loss for 2024 was $9.1M, a major improvement from $20.2M in 2023.
Ended the year with $9.2M in cash, cash equivalents, and restricted cash, supported by $5M from a strategic partner.
Outlook and guidance
Targeting profitability in 2025, with plans to introduce high-impact PBM-based products in the second half of 2025.
Confident in a strong sales pipeline and new business wins, expecting continued revenue growth and margin improvement.
Plans in place to cover cash requirements until reaching cash flow positive in 2025.
Continued focus on cost streamlining and innovative service deployment, including the Empara Member Engagement Portal.
Latest events from Marpai
- Q2 2024 saw a 28% revenue drop, $13M net loss, and a $7.6M impairment charge.MRAI
Q2 20242 Feb 2026 - Q3 2024 losses narrowed as cost cuts offset revenue decline, but liquidity risks remain.MRAI
Q3 202415 Jan 2026 - Board seeks approval for director elections, auditor ratification, and preferred stock authorization.MRAI
Proxy Filing2 Dec 2025 - Shareholders will vote on director elections, auditor ratification, and preferred stock authorization.MRAI
Proxy Filing2 Dec 2025 - Facing ongoing losses and liquidity risks, the company relies on new capital to sustain operations.MRAI
Registration Filing29 Nov 2025 - Q2 2025 saw revenue drop but major cost cuts, with profitability targeted for early 2026.MRAI
Q2 202523 Nov 2025 - Revenue fell 27% to $5.4M; net loss improved, but liquidity and funding risks remain.MRAI
Q1 202519 Nov 2025 - Q3 2025 revenue fell 42%, but cost cuts and new funding drive a turnaround amid liquidity risks.MRAI
Q3 202517 Nov 2025